TO THE EDITOR:
Metabolic re-programming is a hallmark of acute myeloid leukemia (AML) [1]. AML cells co-opt bone marrow niche to utilize fatty acid or amino acids to fuel oxidative phosphorylation (OXPHOS), possibly contributing to resistance [2,3,4,5]. We previously reported leukaemia cells compete over bone marrow micro-environment cells on glucose uptake in a MLL-AF9-driven AML mouse model [6]. Whether glucose uptake by leukaemia cells correlates with response to induction chemotherapy is unknown.
Data availability
Raw bulk RNA-sequencing data have been submitted to the Genome Sequence Archive (Genomics, Proteomics & Bioinformatics 2021) in National Genomics Data Center (Nucleic Acids Res 2022), China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Science (GSA-Human: HRA008200) that are publicly accessible at http://ngdc.cncb.ac.cn/gsa-human.
Code availability
Code used for bioinformatic analysis are available on request from corresponding author. Other data are available in the main text or the supplemental materials.
References
Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473.
Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, et al. Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche. Cell Stem Cell. 2016;19:23–37.
Lin KH, Xie A, Rutter JC, Ahn YR, Lloyd-Cowden JM, Nichols AG, et al. Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity. Cell Metab. 2019;29:1217–31.
van Gastel N, Spinelli JB, Sharda A, Schajnovitz A, Baryawno N, Rhee C, et al. Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. Cell Metab. 2020;32:391–403.
Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discov. 2017;7:716–35.
Deng S, Du J, Gale RP, Wang L, Zhan H, Liu F, et al. Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia. Leukemia. 2023;37:1407–12.
Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593:282–8.
Pilkington P, Lopci E, Adam JA, Kobe C, Goffin K, Herrmann K. FDG-PET/CT Variants and Pitfalls in Haematological Malignancies. Semin Nucl Med. 2021;51:554–71.
Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia. Eur J Radio. 2016;85:205–10.
Alghamdi N, Chang W, Dang P, Lu X, Wan C, Gampala S, et al. A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data. Genome Res. 2021;31:1867–84.
Acknowledgements
Dr. Xiaoxia Hu (Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China), Dr. Min Zhao (Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China) and Dr. Jie Tian (Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, China) kindly reviewed the typescript. We thank Dr. Xi Xu (Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China), Dr. Shaowei Qiu (State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China) for advice in the PDX models. RPG acknowledges support from the UK National Institute of Health Research (NIHR) Biomedical Research Centre.
Funding
Supported, in part, by the Talent Young Program of Guangdong Province (2021B1515020017), National Natural Science Foundation of China (Grant No. 81970143 and No. 82270167), Municipal School Joint Program from Guangzhou Science and Technological Project (202201020012) to HZ.
Author information
Author notes
These authors contributed equally: Suqi Deng, Juan Du.
Authors and Affiliations
Department of Hematology, the First Affiliated Hospital of Jinan University, Guangzhou, China
See AlsoPhysiology, GluconeogenesisSodium moves across membrane by: Diffusion (D) Anti transportat... | FiloSuqi Deng,Juan Du,Kexiu Huang,Danqi Pan,Xue Zheng,Ying Xu,Shengqian Xie&Weihao Xiao
Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK
Robert Peter Gale
Department of Nuclear Medicine and PET/CT-MRI Center, the First Affiliated Hospital of Jinan University, Guangzhou, China
Lu Wang&Junjie Wei
Department of Hematology, Guangzhou First People’s Hospital, Guangzhou, China
Wei Zhou
Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China
Bo Liu,Zhiyang Chen&Zhenyu Ju
Department of Hematology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Hui Zeng
Authors
- Suqi Deng
View author publications
You can also search for this author in PubMedGoogle Scholar
- Juan Du
View author publications
You can also search for this author in PubMedGoogle Scholar
- Kexiu Huang
View author publications
You can also search for this author in PubMedGoogle Scholar
- Robert Peter Gale
View author publications
You can also search for this author in PubMedGoogle Scholar
- Danqi Pan
View author publications
You can also search for this author in PubMedGoogle Scholar
- Lu Wang
View author publications
You can also search for this author in PubMedGoogle Scholar
- Junjie Wei
View author publications
You can also search for this author in PubMedGoogle Scholar
- Xue Zheng
View author publications
You can also search for this author in PubMedGoogle Scholar
- Ying Xu
View author publications
You can also search for this author in PubMedGoogle Scholar
- Shengqian Xie
View author publications
You can also search for this author in PubMedGoogle Scholar
- Wei Zhou
View author publications
You can also search for this author in PubMedGoogle Scholar
- Weihao Xiao
View author publications
You can also search for this author in PubMedGoogle Scholar
- Bo Liu
View author publications
You can also search for this author in PubMedGoogle Scholar
- Zhiyang Chen
View author publications
You can also search for this author in PubMedGoogle Scholar
- Zhenyu Ju
View author publications
You can also search for this author in PubMedGoogle Scholar
- Hui Zeng
View author publications
You can also search for this author in PubMedGoogle Scholar
Contributions
SQD, data curation, experiment conduction, statistical and transcriptomic analysis, visualization, preparing the typescript; JD, data curation, result interpretation, investigation, preparing and editing the typescript; RPG, data interpretation, reviewing and editing the typescript; LW, JJW and SQX, technical support; KXH, DQP, SQX and WHX, experimental assistance; XZ, YX and WZ, clinical data; BL, ZYC and ZYJ, patient-derived xenografts model construction; HZ, project design, investigation, data interpretation, reviewing and editing the typescript. All authors take responsibility for the content of the typescript and agree to submit itfor publication.
Corresponding author
Correspondence to Hui Zeng.
Ethics declarations
Competing interests
RPG is a consultant to NexImmune Inc. Nanexa Pharma Ascentage Pharm Group and Antengene Biotech LLC, Medical Director of FFF Enterprises Inc.; Partner in AZCA Inc.; Board of Directors of Russian Foundation for Cancer Research Support and Scientific Advisory Board: StemRad Ltd.
Ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonization Good Clinical Practice guideline and received approval from the Ethics Committee of the First Affiliated Hospital of Jinan University (KY-2023-117) and is registered on clinicaltrials.gov (NCT05919199). Informed consent was obtained from all participants. All clinical data including PET/CT images and bone marrow samples were obtained and published after written informed consent. The experiments of PDX models were approved by the Institutional Animal Care and Use Committee of Jinan University (JNU-IACUC) and conformed to all relevant regulatory standards. Mice were kept in ventilated cages under pathogen-free conditions with 12 h light and dark cycle and given water and food ad libitum. All 18F-FDG experiments were conducted with the approvals mentioned above and with proper radiation protection.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Deng, S., Du, J., Huang, K. et al. Glucose uptake capacity of leukaemia cells in vitro correlates with response to induction therapy in acute myeloid leukaemia. Leukemia (2024). https://doi.org/10.1038/s41375-024-02469-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41375-024-02469-3